News

Significant risk reduction for death and vascular complications seen with maintaining at least four years of nondiabetes

Reduction seen in cardiovascular events irrespective of baseline HbA1c or change in HbA1c

Patients with overweight, obesity receiving tirzepatide significantly more likely to achieve ≥5, ≥10, and ≥15 percent weight loss

By Beth Gilbert HealthDay ReporterThe annual meeting of the American Diabetes Association was held this year from June 21 to 24 in Orlando, Florida, drawing more than 15,000 participants from around the world, including clinicians, academicians, allied health professionals, and others interested in diabetes. The conference highlighted the latest advances …

24.9 percent received creatinine and UACR screening; Hispanic ethnicity associated with lack of screening

Significant decrease seen in peripheral insulin sensitivity with four-day energy balance diet plus oral BPA administration

Authors say inhaled insulin may provide convenient alternative delivery method

Semaglutide reduces body weight to a greater extent in females; yields similar improvements in heart failure-related symptoms in both sexes

Two randomized controlled trials show reduction in AHI; significant improvements seen in all secondary end points

Within-species phylogenetic diversity identified for strains of 27 species that explain inter-individual differences in type 2 diabetes risk